SEC Form 3 · accession 0001683168-17-001998
US-China Biomedical Technology, Inc. · UCBB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Jul 28, 2017
Accepted (ET)
Aug 8, 2017 · 5:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,500,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On July 28, 2017, the Reporting Person acquired 1,500,000 shares of Issuer's common stock pursuant to a Stock Purchase Agreement, which closed July 28, 2017, between Mr. Michael Dunn, the Reporting Person and China Israel Biotechnology Co. Ltd. The shares were acquired at a cost basis of $0.033 per share.